Cargando…

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)

BACKGROUND: Biological DMARDs (bDMARDs) have been proven to prevent joint damage and bone erosions. Nevertheless, approximately 15% of rheumatoid arthritis (RA) patients on bDMARDs will progress despite good control of joint inflammation. OBJECTIVES: The objective of our study is to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adami, Giovanni, Fassio, Angelo, Pistillo, Francesca, Benini, Camilla, Viapiana, Ombretta, Rossini, Maurizio, Gatti, Davide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540567/ https://www.ncbi.nlm.nih.gov/pubmed/37780955 http://dx.doi.org/10.1177/1759720X231174534

Ejemplares similares

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
por: Adami, Giovanni, et al.
Publicado: (2023)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Acute Phase Reaction and Fracture Risk Reduction: Are Gamma‐Delta T Cells and Hypovitaminosis D the Missing Link?
por: Adami, Giovanni, et al.
Publicado: (2022)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
por: Fassio, Angelo, et al.
Publicado: (2022)

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2021)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment
por: Fassio, Angelo, et al.
Publicado: (2020)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Outcomes with Biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) in Older Patients Treated for Rheumatoid Arthritis
por: Akter, Ripa, et al.
Publicado: (2020)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides
por: Adami, Giovanni, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
por: Cioffi, Giovanni, et al.
Publicado: (2021)

Risk of infection in postmenopausal women with rheumatoid arthritis and osteoporosis taking denosumab and bDMARDS
por: Mirzaei, Alireza, et al.
Publicado: (2021)

Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
por: Sánchez-Piedra, Carlos, et al.
Publicado: (2021)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
por: Bertoldo, Eugenia, et al.
Publicado: (2021)

bDMARD Dose Reduction in Rheumatoid Arthritis: A Narrative Review with Systematic Literature Search
por: Verhoef, Lise M., et al.
Publicado: (2017)

Real-world comparative effectiveness of bDMARDs and JAK inhibitors in elderly patients with rheumatoid arthritis
por: Temmoku, Jumpei, et al.
Publicado: (2022)

Gender disparity in authorship of guidelines and recommendations in rheumatology
por: Adami, Giovanni, et al.
Publicado: (2020)

Clinical factors associated with discontinuation of ts/bDMARDs in rheumatic patients from the BIOBADASER III registry
por: Prior-Español, A., et al.
Publicado: (2021)

Machine learning-based prediction model for responses of bDMARDs in patients with rheumatoid arthritis and ankylosing spondylitis
por: Lee, Seulkee, et al.
Publicado: (2021)

Stopping bDMARDs at the beginning of pregnancy is associated with disease flares and preterm delivery in women with rheumatoid arthritis
por: Gerardi, Maria Chiara, et al.
Publicado: (2022)

The impact of bDMARDs on postoperative complications in patients with rheumatoid arthritis: A systematic review and meta-analysis
por: Suto, Takahito, et al.
Publicado: (2023)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
por: Rotta, Denise, et al.
Publicado: (2020)

HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
por: Gremese, Elisa, et al.
Publicado: (2020)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2020)

Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
por: Fassio, Angelo, et al.
Publicado: (2022)

Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options
por: Bixio, Riccardo, et al.
Publicado: (2022)

Use of a bDMARD or tsDMARD for the management of inflammatory arthritis under checkpoint inhibitors: an observational study
por: De La Fuente, Fanny, et al.
Publicado: (2022)

Incident and recurrent herpes zoster for first-line bDMARD and tsDMARD users in seropositive rheumatoid arthritis patients: a nationwide cohort study
por: Jeong, Seogsong, et al.
Publicado: (2022)

Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity
por: Prawjaeng, Juthamas, et al.
Publicado: (2023)

Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis
por: Lu, Yuqiong, et al.
Publicado: (2022)

Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate
por: Batticciotto, Alberto, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_7di34f1e16i58rk1ce7okht627